EUVIMEDEUVIMED entdecken
Crossref

The Role of [18F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions

Daniele Antonio Pizzuto, Angelo Castello, Marco Chiappetta, Massimo Castellani, Salvatore Annunziata, Annalisa Campanella, Giuseppe Calabrese, Margherita Cattaneo, Lorenzo Rosso, Giacomo Cusumano, Filippo Lococo, Paolo Mendogni

Molecular Diagnosis & Therapy · 2025

DOI: 10.1007/s40291-024-00767-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, 2025. Verfasst von Daniele Antonio Pizzuto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, GSTeP Radiopharmacy-TracerGLab, Department of Radiology, Radiotherapy and Hematology, Fondazione Policlinico Universitario A. …. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Thymus Neoplasms, Thymoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate whether 18F-fluorodeoxyglucose positron emission tomography-computed tomography ([18F]F-FDG PET/CT) metabolic parameters were associated with histology and to assess their prognostic role in patients with thymic lesions. PATIENTS AND METHODS: In total, 116 patients (49/67 M/F; mean age 59.5 years) who underwent preoperative [18F]F-FDG PET/CT and thymectomy from 2012 to 2022 were retrospectively analyzed. Associations between histology and metabolic parameters (maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), peak standardized uptake value (SUVpeak), total lesion glycolysis (TLG), metabolic tumor volume (MTV), ratio between target lesion and liver SUVmax (rPET), quotient of SUVpeak in the tumor residual and SUVmean in a 20-cm3 volume of interest (qPET), and tumor-to-mediastinum (T/M) were analyzed. Freedom from recurrence (FFR) was determined and compared using the Kaplan-Meier and the log-rank test. The median follow-up was 38 months (range 14-72 months). RESULTS: In total, 27 thymic hyperplasia, 41 low-risk thymomas (LRT) (types A, AB, and B1), and 48 high-risk thymomas (HRT) (B2, B3 thymoma, and carcinoma) were included. SUVmax, SUVmean, SUVpeak, rPET, qPET, and T/M were significantly higher in HRT than LRT and hyperplasia (p < 0.001). TLG and MTV were significantly higher in patients with LRT (p < 0.001). Only rPET, qPET, and T/M remained significantly higher in HRT than in LRT subgroups (p = 0.042, p = 0.049, and p = 0.028, respectively). SUVmax, SUVmean, and SUVpeak cutoffs of < 4.3, < 2.87, and 4.03, respectively, significantly distinguished patients with longer FFR (p = 0.009, p = 0.05, and p = 0.05). CONCLUSIONS: Positron emission tomography (PET) metabolic parameters could help to differentiate thymic histotypes. Standardized uptake value (SUV)-based parameters appear promising to predict recurrent disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyThymus NeoplasmsThymomaHumansMaleFemaleMiddle AgedPrognosisAgedAdultRetrospective StudiesRadiopharmaceuticalsAged, 80 and over

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine Unit, GSTeP Radiopharmacy-TracerGLab, Department of Radiology, Radiotherapy and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.
  • Department of Nuclear Medicine, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.
  • Thoracic Surgery, Università Magna Graecia, Catanzaro, Italy. marco.chiappetta@policlinicogemelli.it.
  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
  • Thoracic Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.
  • Thoracic Surgery and Lung Transplantation, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.

Zitieren

APA

Pizzuto, D. A., Castello, A., Chiappetta, M., Castellani, M., Annunziata, S., Campanella, A., Calabrese, G., Cattaneo, M., Rosso, L., Cusumano, G., Lococo, F., & Mendogni, P. (2025). The Role of [18F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00767-1

Vancouver

Pizzuto DA, Castello A, Chiappetta M, Castellani M, Annunziata S, Campanella A, et al. The Role of [18F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions. Molecular Diagnosis & Therapy. 2025. doi:10.1007/s40291-024-00767-1

BibTeX
@article{Pizzuto2025,
  author = {Pizzuto, Daniele Antonio and Castello, Angelo and Chiappetta, Marco and Castellani, Massimo and Annunziata, Salvatore and Campanella, Annalisa and Calabrese, Giuseppe and Cattaneo, Margherita and Rosso, Lorenzo and Cusumano, Giacomo and Lococo, Filippo and Mendogni, Paolo},
  title = {The Role of [18F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions},
  journal = {Molecular Diagnosis & Therapy},
  year = {2025},
  doi = {10.1007/s40291-024-00767-1}
}
Kostenlos starten →